摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-phenyl-2-tosylhydrazinecarbothioamide | 28744-12-9

中文名称
——
中文别名
——
英文名称
N-phenyl-2-tosylhydrazinecarbothioamide
英文别名
4-phenyl-1-(toluene-4-sulfonyl)-thiosemicarbazide;4-Phenyl-1-(toluol-4-sulfonyl)-thiosemicarbazid;1-p-Toluenesulfonyl-4-phenyl-3-thiosemicarbazide;1-p-Toluolsulfonyl-4-phenyl-thiosemicarbazid;p-Toluolsulfonyl-4-phenyl-3-thiosemicarbazid;2-[(4-methylphenyl)sulfonyl]-N-phenylhydrazinecarbothioamide;1-[(4-methylphenyl)sulfonylamino]-3-phenylthiourea
N-phenyl-2-tosylhydrazinecarbothioamide化学式
CAS
28744-12-9
化学式
C14H15N3O2S2
mdl
——
分子量
321.424
InChiKey
YCZRVDXTUMRYJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    197-199 °C (decomp)
  • 沸点:
    469.6±38.0 °C(Predicted)
  • 密度:
    1.373±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    111
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    氯化三(三苯基膦)铜(I)N-phenyl-2-tosylhydrazinecarbothioamide乙醇 为溶剂, 反应 2.0h, 以74%的产率得到chlorido(N-phenyl-2-tosylhydrazinecarbothioamide)bis-triphenylphosphane copper(I)
    参考文献:
    名称:
    Cu(I) complexes with thiosemicarbazides derived from p-toluenesulfohydrazide: Structural, luminescence and biological studies
    摘要:
    Reactions of thiosemicarbazide ligands (L-R: R = cyclohexyl (Cy) or phenyl (Ph)) with [CuCl(PPh3)(3)] led to the formation of colorless Cu(I) complexes of composition [CuCl(PPh3)(2)(L-R)]. Both complexes were characterized by spectroscopic methods and further studied by single crystal X-ray diffractometry. The crystal structures confirmed the tetrahedral geometry for the Cu(I) metal center, which is coordinated by a chlorido, two triphenylphosphane and by the thiosemicarbazide as a neutral S-donor monodentate ligand. Photophysical studies revealed that the complexes exhibit emission at room temperature with maxima around 480 nm. At 77 K, the emission is shifted to higher energy, a characteristic behavior of MLCT emitters. The main low lying molecular orbitals were calculated by TD-DFT and confirmed that the S-0 -> S-1 transitions have mainly MLCT character as well as that the peripheral groups in the thiosemicarbazide ligand play an important role on this transition. Moreover, the emission bands are considerably suppressed in the presence of O-2, indicating the triplet character of the emitter excited states. The intersystem crossing process is also suggested by the energy diagrams built through TD-DFT calculations. Overall, both experimental and theoretical analysis suggest (MLCT)-M-3 radiative decays occurrence for the complexes. Furthermore, biological assays showed that the complexes are active on the intracellular amastigote form of Trypanosoma cruzi (Tulahuen Lac-Z strain), and present a significant cytotoxic effect against metastatic melanoma cells. Finally, no significant toxicity to LLC-MK2 cells was observed, resulting in a therapeutic index of about 30 for one of the complexes, in the same order of magnitude as that of the standard drug benznidazole. (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.poly.2018.08.013
  • 作为产物:
    描述:
    硫代异氰酸苯酯对甲苯磺酰肼四氢呋喃 为溶剂, 以80%的产率得到N-phenyl-2-tosylhydrazinecarbothioamide
    参考文献:
    名称:
    3-芳基磺酰基-5-芳基氨基-1,3,4-噻二唑-2(3H)ones作为抗炎和止痛药。
    摘要:
    制备并测试了具有潜在抗炎和镇痛活性的两个系列的3-芳基磺酰基-5-芳基氨基-1,3,4-噻二唑-2(3H)ones 2。药理结果表明,所有标题化合物均具有芳基磺酰基侧链,具有良好的止痛活性和良好的抗炎特性。通过乙酸扭体试验评估的这两个系列的镇痛曲线表明,化合物2c,2f和2h特别是活性最高。简要讨论了结构活动关系。
    DOI:
    10.1016/s0968-0896(01)00121-3
点击查看最新优质反应信息

文献信息

  • A Facile Method for the Synthesis of Hydrazine-4-oxothiazolidine and Imino-5-oxothiadiazine Derivatives from 1,4-Disubstituted Thiosemicarbazides
    作者:Alaa A. Hassan、Ashraf A. Aly、Tarek I. M. Bedair、Alan B. Brown、Talaat I. El-Emary
    DOI:10.1002/jhet.1655
    日期:2014.1
    1,4‐Disubstituted thiosemicarbazides reacted with dimethyl acetylenedicarboxylate with formation of (2‐hydrazono‐4‐oxothiazolidin‐5‐ylidene)acetates and, in one case, a (2‐imino‐1,3,4‐thiadiazin‐5‐on‐6‐ylidene)acetate. Several mechanistic options involving nucleophilic interaction are presented. The structures of all newly synthesized compounds were identified by 1H NMR, 13C NMR, COSY, HMQC and HMBC
    1,4-二取代的硫代氨基脲与乙炔二甲酸二甲酯反应生成(2-肼基-4-氧杂噻唑啉-5-吡咯)乙酸酯,在一种情况下还生成(2-亚氨基-1,3,4-噻二嗪-5-酮) -6-亚丙基)乙酸酯。介绍了涉及亲核相互作用的几种机理选择。通过1 H NMR,13 C NMR,COSY,HMQC和HMBC光谱数据鉴定所有新合成的化合物的结构。
  • Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAFV600E Dual Inhibitors Endowed with Antiproliferative Activity
    作者:Lamya H. Al-Wahaibi、Essmat M. El-Sheref、Alaa A. Hassan、S. Bräse、M. Nieger、Bahaa G. M. Youssif、Mahmoud A. A. Ibrahim、Hendawy N. Tawfeek
    DOI:10.3390/ph16071014
    日期:——
    a GI50 value of 33 nM. The most potent derivatives were found to be compounds 3a, 3c, 3d, and 3f, with GI50 values ranging from 37 nM to 54 nM. The EGFR-TK and BRAFV600E inhibitory assays’ results matched the antiproliferative assay’s results, with the most potent derivatives, as antiproliferative agents, also being the most potent EGFR and BRAFV600E inhibitors. The docking computations were employed
    2,3,4-三取代噻唑3a-i,在四位有一个甲基,是通过1,4-二取代氨基硫脲与氯丙酮在乙酸乙酯/Et3N中或在回流乙醇中反应合成的。使用核磁共振波谱、质谱和元素分析确定了新化合物的结构。此外,通过X射线分析明确证实了化合物3a的结构。 50 µM 3a-i 的细胞活力测定大于 87%,且所有测试物质均不具有细胞毒性。化合物 3a-i 对四种测试的人类癌细胞系表现出良好的抗增殖活性,GI50 值范围为 37 至 86 nM,而参考厄洛替尼的 GI50 值为 33 nM。发现最有效的衍生物是化合物 3a、3c、3d 和 3f,GI50 值范围为 37 nM 至 54 nM。 EGFR-TK和BRAFV600E抑制测定的结果与抗增殖测定的结果相匹配,作为抗增殖剂的最有效的衍生物也是最有效的EGFR和BRAFV600E抑制剂。对接计算用于研究化合物 3a、3c、3d 和 3f 与 BRAFV600E
  • Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents
    作者:Alice P. Borges、Malu M. S. Obata、Silvia H. Libardi、Rafael O. Trevisan、Victor M. Deflon、Ulrich Abram、Francis B. Ferreira、Luiz Antônio S. Costa、Antonio O. T. Patrocínio、Marcos V. da Silva、Júlio C. Borges、Pedro I. S. Maia
    DOI:10.3390/pharmaceutics16040452
    日期:——
    Leishmaniasis is a group of parasitic diseases with the potential to infect more than 1 billion people; however, its treatment is still old and inadequate. In order to contribute to changing this view, this work consisted of the development of complexes derived from MI metal ions with thioureas, aiming to obtain potential leishmanicidal agents. The thiourea ligands (HLR) were obtained by reactions of
    利什曼病是一组寄生虫病,有可能感染超过 10 亿人;然而,其治疗方法仍然陈旧且不充分。为了改变这种观点,这项工作包括开发 MI 金属离子与硫脲的络合物,旨在获得潜在的杀利什曼病剂。硫脲配体 (HLR) 通过对甲苯磺酰肼与 R-异硫氰酸酯反应获得,并用于与 AgI 和 AuI 的络合反应,导致形成 [M(HLR)2]X 组成的络合物(M = Ag 或Au; X = NO3− 或 Cl−)。所有化合物均通过 FTIR、1H NMR、UV-vis、发射光谱和元素分析进行​​表征。一些代表还通过 ESI-MS 和单晶 XRD 进行了研究。通过 DFT 计算进一步分析了它们的性质。评估了它们对 Vero 细胞的细胞毒性以及对婴儿利什曼原虫和巴西利什曼原虫细胞的细胞外杀利什曼原虫活性。此外,还检查了复合物与巴西乳杆菌 (LbOYE) 的老黄酶的相互作用。生物学测试表明,部分化合物具有显着的杀利什曼原虫
  • Silberg; Proinov, Academia Republicii Populare Romine, Filiala Cluj, Studii si Cercetari de Chimie, 1959, vol. 10, p. 329,332
    作者:Silberg、Proinov
    DOI:——
    日期:——
  • SHARMA, M. P.;UPADHYAYA, J. S.;SRIVASTAVA, S. P.;SWAMI, R. K., INDIAN J. PHARM. SCI., 1981, 43, N 5, 177-179
    作者:SHARMA, M. P.、UPADHYAYA, J. S.、SRIVASTAVA, S. P.、SWAMI, R. K.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐